Active-ingredient Dossier
Drospirenone
Active-ingredient Dossier for Drospirenone (progestin oral contraceptive). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: NEXTSTELLIS
- Brand: ROSIE
- Brand: YASMIN
- Brand: LUCINDA
- Brand: ANGELIQ
- Brand: BROOKE
- Therapeutic area: Reproductive Health
What is
Drospirenone Drospirenone is a progestin oral contraceptive.
Australian brands containing
Drospirenone — NEXTSTELLIS — DROSPIRENONE/ — ANGELIQ — Bella — BROOKE — BROOKLYNN — ISABELLE — LUCINDA — PETIBELLE — ROSALEE — ROSIE — YASMIN
Therapeutic areas
Drospirenone is registered in reproductive health (13 brands) and women's health (9 brands).
Sponsor landscape
The ingredient is marketed by six sponsors: Lupin, Bayer, Arrotex Pharmaceuticals, Maple Healthcare, Nova Pharmaceuticals, and Mayne Pharma.
PBS and regulatory activity
Two brands have PBAC outcomes on record, with the latest PBAC outcome dated 1 March 2025. No brands have AusPARs on record.